Annual report pursuant to Section 13 and 15(d)

Income Taxes

v2.4.0.6
Income Taxes
12 Months Ended
Dec. 29, 2012
Income Taxes [Abstract]  
Income Taxes

NOTE E – INCOME TAXES

Income tax expense (benefit) included in income from net earnings consists of the following:

          Year ended        
    2010     2011     2012  
Current                  
Federal $ 18,026   $ 22,383   $ 27,779  
State   1,502     1,913     1,141  
Foreign   2,956     4,442     4,051  
    22,484     28,738     32,971  
Deferred                  
Federal   1,243     1,044     (145 )
State   113     (71 )   94  
Foreign   (627 )   (2,985 )   (927 )
  $ 23,213   $ 26,726   $ 31,993  

 

The income tax provision, as reconciled to the tax computed at the federal statutory rate of 35% for 2010, 2011, and 2012, is as follows:

          Year ended        
    2010     2011     2012  
Federal income taxes at statutory rate $ 24,102   $ 27,117   $ 34,449  
State income taxes, net of federal tax benefit   1,192     1,373     1,201  
Qualified production activities deduction   (1,320 )   (1,576 )   (2,651 )
All other, net   (761 )   (188 )   (1,006 )
  $ 23,213   $ 26,726   $ 31,993  

 

F-14

 

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) (in thousands, except per share data)

NOTE E – INCOME TAXES – CONTINUED

The significant categories of deferred taxes are as follows:

    December 31,     December 29,  
    2011     2012  
Deferred tax assets            
Inventory differences $ 2,695   $ 2,415  
Accruals not currently deductible   2,124     2,533  
Equity-based compensation   7,558     4,375  
Intangible assets   9,535     9,532  
Net operating losses   2,654     2,240  
Other   1,361     2,675  
Gross deferred tax assets   25,927     23,770  
Valuation allowance   (1,784 )   (1,598 )
Net deferred tax assets   24,143     22,172  
 
Deferred tax liabilities            
Depreciation/amortization   (3,506 )   (5,260 )
Accumulated other comprehensive income   (3,378 )   (3,833 )
Prepaid expenses   (1,967 )   (1,240 )
Intangible assets   (10,659 )   (10,521 )
Other   (1,202 )   (2,490 )
Gross deferred tax liabilities   (20,712 )   (23,344 )
Net deferred taxes $ 3,431   $ (1,172 )

 

     At December 29, 2012, the Company had foreign operating loss carry forwards of approximately $8,960. If these operating losses are not used, they will expire between 2013 and 2017. A valuation allowance of approximately $6,400 has been placed on these foreign operating loss carry forwards. The valuation allowance is determined using a more likely than not realization criteria and is based upon all available positive and negative evidence, including future reversals of temporary differences. A future increase or decrease in the current valuation allowance is not expected to impact the income tax provision due to the Company's ability to fully utilize foreign tax credits associated with taxable income in these jurisdictions.

The Components of deferred taxes, net on a jurisdiction basis are as follows:

    December 31,   December 29,  
    2011   2012  
Net current deferred tax assets $ 3,320 $ 4,255  
Net noncurrent deferred tax assets   11,033   5,956  
Total net deferred tax assets   14,353   10,211  
 
Net current deferred tax liabilities   974   1,382  
Net noncurrent deferred tax liabilities   9,948   10,001  
Total net deferred tax liabilities   10,922   11,383  
Net deferred taxes $ 3,431 $ (1,172 )